WADE JEFFREY L 4
4 · LEXICON PHARMACEUTICALS, INC. · Filed Feb 29, 2024
Insider Transaction Report
Form 4
WADE JEFFREY L
EVP, Gen. Counsel
Transactions
- Exercise/Conversion
Common Stock
2024-02-28+49,113→ 361,905 total - Tax Payment
Common Stock
2024-02-28$2.62/sh−37,691$98,750→ 324,214 total - Exercise/Conversion
Restricted Stock Units
2024-02-28−11,177→ 0 total→ Common Stock (11,177 underlying) - Exercise/Conversion
Restricted Stock Units
2024-02-28−37,274→ 37,273 total→ Common Stock (37,274 underlying) - Exercise/Conversion
Common Stock
2024-02-28+37,274→ 312,792 total - Exercise/Conversion
Restricted Stock Units
2024-02-28−49,113→ 98,227 total→ Common Stock (49,113 underlying) - Exercise/Conversion
Common Stock
2024-02-28+11,177→ 275,518 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.